BIOENGINEER

Half-Dose Rivaroxaban Cuts Bleeding After Surgery Without Raising Clot Risk, Study Finds

A propensity scoreā€“matched cohort study found that postoperative patients with isolated distal deep vein thrombosis treated ...
BIOENGINEER

Neoadjuvant Therapy Lengthens Surgery Time but Not Complication Risk in Transanal Rectal Cancer Operations

A multicenter Japanese propensity score-matched analysis of 294 rectal cancer patients found that neoadjuvant therapy before ...

The wrist can extend, but the base of the fingers cannot

Someone came to me saying that for several weeks, it has been difficult to extend the fingers of their right hand. They can ...

Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II / III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced a clinical trial collaboration with the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) to evaluate ivonescimab, a novel, potential first-in-class ...

Recurrence risk halved after colon cancer surgery!? Atezolizumab + FOLFOX, a new frontier in immunotherapy shown by the ATOMIC trial

NEJM 2026, Phase III ATOMIC Trial. Immune checkpoint inhibitors have done it againšŸ¤¤. On October 8, 2026, the U.S. FDA ...
Pitcher List

Breaking Down Late Samples from 2026 for Dynasty: Hitter Edition

Canzone entered 2026 as a platoon bat coming off an .840 OPS season, mostly against right-handers. MLB.comā€™s Daniel Kramer had named him Seattleā€™s breakout candidate, and for once the offseason ...